Protect Yourself During Flu Season: COVID, Flu, and RSV
As flu season approaches, Americans are now facing the added threat of the COVID-19 virus and respiratory syncytial virus (RSV). Dr. Katherine Baumgarten, the medical director of infection control and prevention for Ochsner Health in New Orleans, warns that there is concern for a potential “tripledemic” with COVID, flu, and RSV cases rising simultaneously.
To combat this, vaccines for each of these viruses are now available for the first time this winter. “It is important to receive vaccinations against these viruses ahead of fall and winter, especially for those who are immunocompromised or have underlying health conditions,” advises Dr. Baumgarten.
It is crucial to consult with your own healthcare provider to discuss the best options for vaccination based on your individual health conditions. Read on to learn more about staying safe this winter season.
COVID booster recommended for 2023
A recent surge in COVID-19 infections is partly due to Americans’ waning immunity and vaccine fatigue. The dominant strain in the US currently is the EG.5 variant, also known as “Eris.” COVID-19 hospitalizations have increased by 16% for the week ending Aug. 26, according to the CDC.
Dr. Baumgarten strongly recommends getting a COVID booster shot as soon as possible. While COVID hospitalizations are lower compared to previous years, receiving a booster shot is still essential. A reformulated COVID-19 vaccination with additional protection will become available in early October.
Timing is key for flu vaccination
The CDC recommends annual flu vaccination for everyone aged 6 months and older, with rare exceptions. The vaccine is typically 40-60% effective in preventing doctor visits when it closely matches the circulating strains. Experts suggest getting vaccinated during September or October to develop immunity before flu season peaks.
RSV monoclonal antibody for infants
RSV, a highly contagious virus that causes lung infections, is a significant concern for infants. There is currently no RSV vaccine available for children, but the FDA has approved two monoclonal antibodies, nirsevimab (Beyfortus) and palivizumab (Synagis), to fight RSV. These antibodies provide passive immunity and neutralize the virus before it can cause harm in the body.
Nirsevimab is recommended for infants younger than 8 months who are born during RSV season, which usually coincides with flu season from fall to spring. Palivizumab is given to children under 24 months with medical illnesses that place them at high risk for severe RSV disease.
RSV vaccines available for older adults
Older adults are at risk of developing life-threatening pneumonia and bronchiolitis due to RSV infection. The FDA has approved two RSV vaccines, Arexvy and Abrysvo, for individuals aged 60 and older. Abrysvo is also indicated for pregnant women. These vaccines provide protection against RSV for at least two winter seasons.
However, it’s important to note that a small percentage of patients who received RSV vaccines in clinical trials developed rare inflammatory neurologic events. The CDC recommends “shared decision-making” between individuals and their healthcare providers to evaluate the risks and benefits of the vaccine.
Getting all three vaccines
According to Dr. Baumgarten, it is acceptable for adults to receive all three vaccines (COVID, flu, and RSV) at the same time. However, it is also permissible to receive the vaccines at different times. It’s important to weigh the possible increase in local and other side effects against the likelihood of individuals not getting vaccinated at all if the vaccines are separated over time.
By taking proactive measures and getting vaccinated, you can protect yourself against the “tripledemic” of COVID, flu, and RSV, ensuring a safer winter season.
Denial of responsibility! Vigour Times is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
